MERCURY LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of MERCURY LABORATORIES have increased by 0.30% YoY .
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 1.36 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
MERCURY LABORATORIES Last 5 Annual Financial Results
[BOM: 538964]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹76 Cr | ₹75 Cr | ₹58 Cr | ₹69 Cr | ₹57 Cr |
| Expenses | ₹67 Cr | ₹67 Cr | ₹51 Cr | ₹59 Cr | ₹51 Cr |
| Operating Profit (Excl OI) | ₹9.03 Cr | ₹8.57 Cr | ₹6.99 Cr | ₹9.59 Cr | ₹6.17 Cr |
| Other Income | ₹1.09 Cr | ₹1.72 Cr | ₹0.82 Cr | ₹0.88 Cr | ₹0.85 Cr |
| Interest | ₹0.38 Cr | ₹0.36 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹0.82 Cr |
| Depreciation | ₹2.82 Cr | ₹2.48 Cr | ₹2.45 Cr | ₹1.92 Cr | ₹1.87 Cr |
| Profit Before Tax | ₹6.92 Cr | ₹7.45 Cr | ₹5.03 Cr | ₹7.91 Cr | ₹4.33 Cr |
| Profit After Tax | ₹5.65 Cr | ₹5.58 Cr | ₹3.56 Cr | ₹5.34 Cr | ₹3.23 Cr |
| Earnings Per Share (Rs) | ₹47.12 | ₹46.49 | ₹29.68 | ₹44.48 | ₹26.90 |
| PAT Margin (%) | 7.48 | 7.41 | 6.15 | 7.78 | 5.64 |
| ROE(%) | 11.72 | 12.98 | 9.23 | 15.50 | 10.59 |
| ROCE(%) | 13.61 | 16.19 | 12.26 | 20.56 | 13.25 |
| Total Debt/Equity(x) | 0.11 | 0.12 | 0.13 | 0.19 | 0.22 |
Key Financials |
||
| Market Cap | : | ₹ 108.2 Cr |
| Revenue (TTM) | : | ₹ 69.4 Cr |
| Net Profit(TTM) | : | ₹ 4.0 Cr |
| EPS (TTM) | : | ₹ 33.2 |
| P/E (TTM) | : | 27.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MERCURY LABORATORIES | -2.2% | -2.6% | 17.5% |
| SUN PHARMACEUTICAL INDUSTRIES | 1% | 0.7% | 47.3% |
| CIPLA | 0.3% | -1.8% | 19.6% |
| DR REDDYS LABORATORIES | 6% | 11.8% | 20.3% |
| ZYDUS LIFESCIENCES | -1.5% | -0.1% | 47% |
| DIVIS LABORATORIES | -1.1% | -5.8% | 61.7% |
| MANKIND PHARMA | 3.7% | 11.4% | 59.4% |
| TORRENT PHARMACEUTICALS | 0.6% | 4.1% | 59.5% |
| LUPIN | 3.3% | 2.9% | 75.9% |
MERCURY LABORATORIES Revenues
[BOM: 538964]
| Y-o-Y | 0.30 % |
| 5 Yr CAGR | 7.17 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹76 Cr | 0.30 | |
| Mar2023 | ₹75 Cr | 30.06 | |
| Mar2022 | ₹58 Cr | -15.57 | |
| Mar2021 | ₹69 Cr | 19.79 | |
| Mar2020 | ₹57 Cr | - | |
MERCURY LABORATORIES Operating Profit
[BOM: 538964]
| Y-o-Y | 5.36 % |
| 5 Yr CAGR | 10.01 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹9.03 Cr | 5.36 | |
| Mar2023 | ₹8.57 Cr | 22.62 | |
| Mar2022 | ₹6.99 Cr | -27.12 | |
| Mar2021 | ₹9.59 Cr | 55.55 | |
| Mar2020 | ₹6.17 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 5.01 % |
| 5 Yr CAGR | 2.63 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 11.95% | 5.01 | |
| Mar2023 | 11.38% | -5.72 | |
| Mar2022 | 12.07% | -13.66 | |
| Mar2021 | 13.98% | 29.81 | |
| Mar2020 | 10.77% | - | |
MERCURY LABORATORIES Profit After Tax
[BOM: 538964]
| Y-o-Y | 1.34 % |
| 5 Yr CAGR | 15.04 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.65 Cr | 1.34 | |
| Mar2023 | ₹5.58 Cr | 56.63 | |
| Mar2022 | ₹3.56 Cr | -33.27 | |
| Mar2021 | ₹5.34 Cr | 65.37 | |
| Mar2020 | ₹3.23 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.94 % |
| 5 Yr CAGR | 7.31 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 7.48 % | 0.94 | |
| Mar2023 | 7.41 % | 20.49 | |
| Mar2022 | 6.15 % | -20.95 | |
| Mar2021 | 7.78 % | 37.94 | |
| Mar2020 | 5.64 % | - | |
MERCURY LABORATORIES Earnings Per Share (EPS)
[BOM: 538964]
| Y-o-Y | 1.36 % |
| 5 Yr CAGR | 15.04 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹47 | 1.36 | |
| Mar2023 | ₹46 | 56.64 | |
| Mar2022 | ₹30 | -33.27 | |
| Mar2021 | ₹44 | 65.35 | |
| Mar2020 | ₹27 | - | |
MERCURY LABORATORIES Return on Capital Employed (ROCE)
[BOM: 538964]
| Y-o-Y | -15.94 % |
| 5 Yr CAGR | 0.67 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 13.61% | -15.94 | |
| Mar2023 | 16.19% | 32.06 | |
| Mar2022 | 12.26% | -40.37 | |
| Mar2021 | 20.56% | 55.17 | |
| Mar2020 | 13.25% | - | |
MERCURY LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹901.3 |
| Current MarketCap | : | ₹ 108.2 Cr |
| Updated EOD on | : | Dec 24,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MERCURY LABORATORIES | -2.2% |
-2.6% |
17.5% |
| SENSEX | -2.7% |
-0.8% |
9.9% |
MERCURY LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about MERCURY LABORATORIES Financials
How the annual revenues of MERCURY LABORATORIES have changed ?
The Revenues of MERCURY LABORATORIES have increased by 0.30% YoY .
How the Earnings per Share (EPS) of MERCURY LABORATORIES have changed?
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 1.36 % YoY .
Check out Intrinsic Value of Peers of MERCURY LABORATORIES
Compare Stock Analytics of Peers of MERCURY LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
